ArticleJournal of experimental & clinical cancer research : CR2019

Topoisomerase inhibitors promote cancer cell motility via ROS-mediated activation of JAK2-STAT1-CXCL1 pathway.

Jiafei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.